Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials
- Post by: Claudio Pergolizzi
- February 18, 2020
- Comments off
Categories: